Company page

Pure Bioscience

Pure Bioscience is a public company traded under the ticker PURE in the American market, with a market capitalization of approximately $9.1 million. The company focuses on developing and commercializing innovative bioscience products. Its commitment to advancing technology in the bioscience sector positions it as a notable player in the industry.

profilePURE:OTCAI content: aiUpdated June 24, 2026/company/pure-bioscience-inc/c-rotztsne
Pure Bioscience logo
Ticker
PURE:OTC
Asset type
Stock
Market cap
$9.1M
Sector
Process Industries
Industry
Chemicals: Major Diversified
Exchange
OTC
Currency
USD